Leah Boyer

Leah Boyer

Auto-generated profile, based on publicly available information

Leah Boyer

Laboratory of Genetics, Salk Institute, La Jolla, United States

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BWBeate Winner
Beate Winner
RJRoberto Jappelli
Roberto Jappelli
SMSamir K Maji
Samir K Maji
PDPaula A. Desplats
Paula A. Desplats
LBLeah Boyer
Leah Boyer
RRRoland Riek
Roland Riek
The aggregation of proteins into oligomers and amyloid fibrils is characteristic of several neurodegenerative diseases, including Parkinson disease (PD). In PD, the process of aggregation of α-synuclein (α-syn) from monomers, via oligomeric intermediates, into amyloid fibrils is considered the disease-causative toxic mechanism. We developed α-syn mutants that promote oligomer or fibril formation and tested the toxicity of these mutants by using a rat lentivirus system to investigate loss of dopaminergic neurons in the substantia nigra. The most severe dopaminergic loss in the substantia nigra is observed in animals with the α-syn variants that form oligomers (i.e., E57K and E35K), whereas the α-syn variants that form fibrils very quickly are less toxic. We show that α-syn oligomers are toxic in vivo and that α-syn oligomers might interact with and potentially disrupt membranes.

1 April 2009 in Cell
Verified
Journal Article
Closed access
KSKaoru Saijo
Kaoru Saijo
BWBeate Winner
Beate Winner
CCChristian T. Carson
Christian T. Carson
JCJana G. Collier
Jana G. Collier
LBLeah Boyer
Leah Boyer
CGChristopher K. Glass
Christopher K. Glass

10 June 2016 in eLife
Verified
Journal Article
Open access
XZXinde Zheng
Xinde Zheng
LBLeah Boyer
Leah Boyer
MJMingji Jin
Mingji Jin
JMJerome Mertens
Jerome Mertens
YKYongsung Kim
Yongsung Kim
THTony Hunter
Tony Hunter
How metabolism is reprogrammed during neuronal differentiation is unknown. We found that the loss of hexokinase (HK2) and lactate dehydrogenase (LDHA) expression, together with a switch in pyruvate kinase gene splicing from PKM2 to PKM1, marks the transition from aerobic glycolysis in neural progenitor cells (NPC) to neuronal oxidative phosphorylation. The protein levels of c-MYC and N-MYC, transcriptional activators of the HK2 and LDHA genes, decrease dramatically. Constitutive expression of HK2 and LDHA during differentiation leads to neuronal cell death, indicating that the shut-off aerobic glycolysis is essential for neuronal survival. The metabolic regulators PGC-1α and ERRγ increase significantly upon neuronal differentiation to sustain the transcription of metabolic and mitochondrial genes, whose levels are unchanged compared to NPCs, revealing distinct transcriptional regulation of metabolic genes in the proliferation and post-mitotic differentiation states. Mitochondrial mass increases proportionally with neuronal mass growth, indicating an unknown mechanism linking mitochondrial biogenesis to cell size.

28 October 2015 in Nature
Verified
Journal Article
Closed access
PDF file
TSThe Pharmacogenomics of Bipolar Disorder Study
The Pharmacogenomics of Bipolar Disorder Study
JMJerome Mertens
Jerome Mertens
QWQiu-Wen Wang
Qiu-Wen Wang
YKYongsung Kim
Yongsung Kim
DYDiana X. Yu
Diana X. Yu
JYJun Yao
Jun Yao

13 April 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CBCedric Bardy
Cedric Bardy
MHMark van Den Hurk
Mark van Den Hurk
TETameji Eames
Tameji Eames
CMCynthia Marchand
Cynthia Marchand
RHRuben V. Hernandez
Ruben V. Hernandez
FGFred H. Gage
Fred H. Gage
Human cell reprogramming technologies offer access to live human neurons from patients and provide a new alternative for modeling neurological disorders in vitro. Neural electrical activity is the essence of nervous system function in vivo. Therefore, we examined neuronal activity in media widely used to culture neurons. We found that classic basal media, as well as serum, impair action potential generation and synaptic communication. To overcome this problem, we designed a new neuronal medium (BrainPhys basal + serum-free supplements) in which we adjusted the concentrations of inorganic salts, neuroactive amino acids, and energetic substrates. We then tested that this medium adequately supports neuronal activity and survival of human neurons in culture. Long-term exposure to this physiological medium also improved the proportion of neurons that were synaptically active. The medium was designed to culture human neurons but also proved adequate for rodent neurons. The improvement in BrainPhys basal medium to support neurophysiological activity is an important step toward reducing the gap between brain physiological conditions in vivo and neuronal models in vitro.

12 September 2012 in Nature
Verified
Journal Article
Closed access
PDF file
DVDavid Vilchez
David Vilchez
LBLeah Boyer
Leah Boyer
IMIanessa Morantte
Ianessa Morantte
MLMargaret Lutz
Margaret Lutz
CMCarsten Merkwirth
Carsten Merkwirth
ADAndrew Dillin
Andrew Dillin